Growth factor and sex steroid interactions in breast cancer.
Mitogenic and inhibitory growth factors and steroid ovarian hormones play important roles as selective modulators of normal mammary development and in the onset and the progression of human breast cancer. The focus of this article is to review past and current research on the interactions of these two classes of effectors in mammary gland development and neoplasia. Steroid hormones regulate synthesis of growth stimulatory and inhibitory growth factors, growth factor receptors, and growth factor binding proteins. In turn, growth factor pathways may modulate phosphorylation and function of steroid receptors and potentiate or inhibit the mitogenic actions of steroids. Ultimately, during the progression of the malignant mammary epithelial cell to hormonal autonomy, overexpression, mutation, or disregulation of key elements of growth factor signal transduction pathways all may play critical roles.
Kenney
N J
NJ
Lombardi Cancer Center, Georgetown University, Washington, D.C. 20007, USA.
Dickson
R B
RB
D000818:Animals; D019898:Autocrine Communication; D001943:Breast Neoplasms / Q000378:metabolism*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism; D019899:Paracrine Communication
D012739:Gonadal Steroid Hormones; D006133:Growth Substances